The Europe biosimilar market reached USD 10.13 Billion in 2024, driven by the growing use of biosimilars in managing chronic diseases. It is expected to grow at a CAGR of 12.80% from 2025 to 2034, reaching nearly USD 33.78 Billion by 2034. https://www.expertmarketresearch.com/reports/europe-biosimilar-market